Literature DB >> 27978522

Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.

Peter C Konturek1, Drilon Haziri, Harry Helfritzsch, Thomas Hess, Igor A Harsch.   

Abstract

OBJECTIVE: The aim of this work was to describe the use of a combination of fidaxomicin and fecal microbiota therapy (FMT) in Clostridium difficile infection (CDI). CLINICAL PRESENTATION AND INTERVENTION: A 78-year-old female, who was admitted for surgery due to acute diverticulitis caused by postoperative complications and broad antibiotic therapy, developed CDI-induced colitis. Despite the introduction of metronidazole and vancomycin therapy, her clinical condition continued to deteriorate. She was transferred to the intensive care unit where FMT followed by fidaxomicin were performed because her C-reactive protein and leucocyte levels remained elevated. Further clinical improvement and the resolution of colitis was observed.
CONCLUSION: In this case, severe CDI colitis was successfully treated with the combination of FMT and fidaxomicin.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27978522      PMCID: PMC5588376          DOI: 10.1159/000455126

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  10 in total

1.  Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection.

Authors:  S Pecere; M Sabatelli; M Fantoni; G Ianiro; A Gasbarrini; G Cammarota
Journal:  Aliment Pharmacol Ther       Date:  2015-10       Impact factor: 8.171

Review 2.  Clostridium difficile Infection.

Authors:  Christopher L Knight; Christina M Surawicz
Journal:  Med Clin North Am       Date:  2013-04-24       Impact factor: 5.456

3.  Clostridium difficile infection: risk factors, diagnosis and management.

Authors:  Christina M Surawicz
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

4.  Audit of physicians' adherence to the antibiotic policy guidelines in Kuwait.

Authors:  Nasser Y Aly; Abeer A Omar; Dina A Badawy; Haifa H Al-Mousa; Ali A Sadek
Journal:  Med Princ Pract       Date:  2012-01-12       Impact factor: 1.927

5.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

Review 6.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.

Authors:  Jessica S H Martin; Tanya M Monaghan; Mark H Wilcox
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

7.  Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.

Authors:  Monika Fischer; Dina Kao; Shama R Mehta; Tracey Martin; Joseph Dimitry; Ammar H Keshteli; Gwendolyn K Cook; Emmalee Phelps; Brian W Sipe; Huiping Xu; Colleen R Kelly
Journal:  Am J Gastroenterol       Date:  2016-05-17       Impact factor: 10.864

8.  A case of toxic megacolon caused by clostridium difficile infection and treated with fecal microbiota transplantation.

Authors:  Tae Geun Gweon; Kyung Jin Lee; Dong Hoon Kang; Sung Soo Park; Kyung Hoon Kim; Hyeon Jin Seong; Tae Hyun Ban; Sung Jin Moon; Jin Su Kim; Sang Woo Kim
Journal:  Gut Liver       Date:  2015-03       Impact factor: 4.519

Review 9.  Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection.

Authors:  George G Zhanel; Andrew J Walkty; James A Karlowsky
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Nov-Dec       Impact factor: 2.471

Review 10.  Clostridium difficile infection: a review of current and emerging therapies.

Authors:  Andrew Ofosu
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun
  10 in total
  2 in total

1.  Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.

Authors:  Wenjia Hui; Ting Li; Weidong Liu; Chunyan Zhou; Feng Gao
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

Review 2.  Role of Fecal Microbiota Transplantation in Reducing Clostridioides difficile Infection-Associated Morbidity and Mortality: A Systematic Review.

Authors:  Adarsh Srinivas Ramesh; Carlos Munoz Tello; Dawood Jamil; Hadrian Hoang-Vu Tran; Mafaz Mansoor; Samia Rauf Butt; Travis Satnarine; Pranuthi Ratna; Aditi Sarker; Safeera Khan
Journal:  Cureus       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.